| Select presentations below in the following formats where these icons appear: | ||
|
||
Monday, May 8, 2006 |
||
| 8:30 am | Registration | |
| 9:00-9:30 am | Welcome and Introduction | |
| Kenneth P. Moritsugu, M.D. Deputy Surgeon General and Workshop Chair Office of the Surgeon General |
||
| Elizabeth Nabel, M.D. Director, National Heart, Lung, and Blood Institute |
||
| Richard Carmona, M.D., M.P.H.,
F.A.C.S. Surgeon General |
||
| Thomas L. Ortel, M.D., Ph.D. Science Co-Chair Duke University Medical Center |
||
| Samuel Z. Goldhaber, M.D. Science Co-Chair Harvard Medical School |
||
| Heidi Blongastainer DVT patient |
||
| Melanie Bloom National DVT Patient Spokesperson |
||
| Kenneth P. Moritsugu, M.D. | ||
| 9:30-10:45 am | Panel #1: Epidemiology of Deep Vein Thrombosis | |
| Epidemiology of
Venous Thromboembolism Text alternative for slides |
John A. Heit, M.D. Mayo Clinic  1.9 MB 652 KB 252 KB |
|
| Modifiable and
Non-Modifiable Risk Factors for Venous Thromboembolism Text alternative for slides |
Mary Cushman, M.D. University of Vermont 88 KB 2.1 MB 324 KB |
|
| Thrombosis in the
Pediatric Patient: Unique Risk Factors, Diagnosis, and Management Issues Text alternative for slides |
Marilyn Manco-Johnson, M.D. University of Colorado 44
KB 19.1 MB 476 KB |
|
| Sequelae and Cost of
Venous Thromboembolism Text alternative for slides |
Samuel Z. Goldhaber, M.D. Harvard Medical School 10.3 MB 2.8 MB 352 KB |
|
| Summary |
Thomas L. Ortel, M.D., Ph.D. Duke University Medical Center |
|
| 10:45-11:00 am | Break | |
| 11:00 am-12:00 noon | Panel #2: High-Risk Groups for Deep Vein Thrombosis | |
| Venous
Thromboembolism in the Cancer Patient Text alternative for slides |
Ajay Kakkar, M.B.B.S., Ph.D. Queen Mary University of London and Thrombosis Research Institute 16 KB 1.1 MB
156 KB |
|
| Women's Issues:
Pregnancy, Oral Contraceptives, and Hormone Replacement Therapy Text alternative for slides |
Suman Rathbun, M.D., M.S. University of Oklahoma Health Sciences Center
232 KB 116 KB
540 KB |
|
| General Surgery, Orthopedic Surgery, Trauma, and Immobility | Lt. Col. Donald H. Jenkins, M.D. USAF, Chairman, General Surgery and Chief of Trauma Services, 59th Medical Wing, Wilford Hall Medical Center
152 KB 32 KB 24 KB |
|
| Summary | Thomas L. Ortel, M.D., Ph.D. Duke University Medical Center |
|
| 12:00-1:00 pm | Lunch | |
| 1:00-2:00 pm | Panel #3: Diagnosing Deep Vein Thrombosis | |
| Diagnosis of Deep
Venous Thrombosis and Pulmonary Embolism Text alternative for slides |
Jeffrey I. Weitz, M.D. McMaster University, Hamilton, Canada
512 KB 2.6
MB 236 KB |
|
| Feasibility of a
National Screening Program for Venous Disease Text alternative for slides |
Robert B. McLafferty, M.D. Southern Illinois University 36
KB 1.9 MB 120
KB |
|
| Laboratory Testing
and the Thrombophilia Workup Text alternative for slides |
Thomas L. Ortel, M.D., Ph.D. Duke University Medical Center
270 KB 416 KB 160
KB |
|
| Summary | Samuel Z. Goldhaber, M.D | |
| 2:00-3:00 pm | Panel #4: Approaches to Treating Deep Vein Thrombosis | |
| Anticoagulant
Therapies and the Treatment of Venous Thromboembolism Text alternative for slides |
Kenneth A. Bauer, M.D. Harvard Medical School 40 KB 388 KB
116 KB |
|
| Management Issues
With Oral Anticoagulant Therapy Text alternative for slides |
Jack E. Ansell, M.D. Boston University 40 KB 1.1 MB
136
KB |
|
| Aggressive
Intervention Strategies and the Role of Graduated Compression Stockings Text alternative for slides |
Thomas W. Wakefield, M.D University of Michigan
104 KB 204 KB 324 KB |
|
| Summary | Thomas L. Ortel, M.D., Ph.D. Duke University Medical Center |
|
| 3:00-3:15 pm | BREAK | |
| 3:15-4:30 pm | Panel #5: Awareness and Best Practices Regarding Deep Vein Thrombosis | |
| Awareness and Best
Practices Regarding Deep Vein Thrombosis Text alternative for slides |
Franklin A. Michota, M.D Cleveland Clinic Foundation 5.4 MB 824 KB |
|
| Update on National
Quality Forum Activities Related to DVT Text alternative for slides |
Lisa Hines, M.S. National Quality Forum 168 KB 80 KB |
|
| Question Session 1 | Samuel Z. Goldhaber, M.D., Moderator | |
| Personal
Perspectives on Venous Thromboembolism and the Role of Patient Advocacy
Groups Text alternative for slides |
Mark Jablonski President, National Alliance for Thrombosis and Thrombophilia 32 KB 1.8 MB
68
KB |
|
| Personal Perspective on Venous Thromboembolism | Michael Hefron DVT patient 32 KB |
|
| Question Session 2 | Samuel Z. Goldhaber, M.D., Moderator Panel Members: Heidi Blongastainer Melanie Bloom |
|
| Summary | Samuel Z. Goldhaber, M.D. Harvard Medical School |
|
| 4:30-5:00 pm | Review of Day 1 With Discussion; Overview of Day 2 | Dr. Moritsugu, Dr. Goldhaber, and Dr. Ortel |
Tuesday, May 9, 2006 |
||
| 8:30-9:30 am | Panel #6: Prevention of Deep Vein Thrombosis | |
| Venous
Thromboembolism Practice for the Medical Patient Text alternative for slides |
John A. Heit, M.D. Mayo Clinic 112 KB 204 KB
152
KB |
|
| Thrombosis Risk
Assessment as a Guide to Thrombosis Prophylaxis in the Surgical Patient Text alternative for slides |
Joseph A. Caprini, M.D. Northwestern University 40
KB 608 KB 152 KB |
|
| Strategies To
Improve Use of Thromboprophylaxis for Venous Thromboembolism Text alternative for slides |
Samuel Z. Goldhaber, M.D. Harvard Medical School
796 KB 108 KB 132
KB |
|
| Summary | Thomas L. Ortel, M.D., Ph.D. Duke University Medical Center |
|
| 9:30-10:30 am | Panel #7: Translation and Application Issues in Relation to Deep Vein Thrombosis | |
| Translation of
Evidence-Based Data Into Clinical Practice Text alternative for slides |
Joseph A. Caprini, M.D. Northwestern University 24
KB 792 KB 228 KB |
|
| Unique Needs for
Women and the Pediatric Patient Population Text alternative for slides |
Andra H. James, M.D. Duke University Medical Center 140 KB 52 KB 40 KB |
|
| Strategies To
Improve Use of Thromboprophylaxis for Venous Thromboembolism Text alternative for slides |
Stephan Moll, M.D. University of North Carolina, Chapel Hill 196 KB 1.3 MB
156 KB |
|
| Summary | Samuel Z. Goldhaber, M.D. Harvard Medical School |
|
| 10:30-10:45 am | Break | |
| 10:45 am-12:15 pm | Small-Group Discussions | |
| 12:15-1:15 pm | Lunch | |
| 1:15-2:45 pm | Small-Group Reports and Discussion | |
| Group A: Clinical Approaches to Enhancing Diagnosis and Treatment | ||
| Group B: Primary Prevention of VTE | ||
| Group C: Enhancing
the DVT Science Base and Accelerating Clinical and Public Health
Applications |
||
| Group D: Public
Health Priorities |
||
| Group E: Enhancing Existing Collaborations and Developing New Partnerships | ||
| 2:45-3:45 pm | Summary and
Consideration of Priority Areas for Action Text alternative for slides |
Dr. Moritsugu, Dr. Goldhaber, and Dr. Ortel 28 KB
48
KB |
| 3:45-4:00 pm | Closing Remarks and Next Steps | Dr. Richard Carmona U.S. Surgeon General |